Philadelphia, PA, USA
Shaping the Future of T1D.
Join us for the inaugural edition of the
Clinical & Research Congress
The inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026) is a groundbreaking forum uniting clinicians, researchers, scientists, healthcare professionals, industry leaders, and the T1D community. Over two and a half inspiring days, you will explore cutting-edge advances in type 1 diabetes discovery science, immunotherapies, automated insulin delivery, islet cell therapies, psychosocial care, health equity, and more. Designed to foster collaboration and spark innovation, CRC 2026 will provide translational insights, interactive learning, and meaningful dialogue, all with one shared goal: improving lives and driving toward a world without T1D.
Breakthrough T1D: past, present, and future
Founded in 1970 by families determined to change the future of type 1 diabetes, Breakthrough T1D is the leading global nonprofit driving research, advocacy, and innovation to cure, prevent, and treat T1D.
Guided by our expert Advisory Board
The Breakthrough T1D Clinical & Research Congress 2026 will be guided by our expert Scientific Advisory Board, comprising leading clinicians, researchers, and thought leaders in type 1 diabetes. Their expertise ensures a cutting-edge, clinically relevant, and multidisciplinary program.
Congress Co-Chair
Thomas Danne
Congress Co-Chair
Sanjoy Dutta
Congress Co-Chair
Anastasia Albanese-O’Neill
Take part in a state-of-the-art scientific program
CRC 2026 will feature a rich, multidisciplinary scientific program designed to showcase the most significant advances in type 1 diabetes (T1D) science, clinical care, and innovation.
Hear from leading international speakers
The Congress will feature a lineup of internationally recognized speakers who are leaders in clinical care, discovery research, and innovation, and are shaping the future of type 1 diabetes treatment and prevention.
Who attends?
This meeting is a must-attend for anyone committed to shaping the future of type 1 diabetes care and cures, including healthcare providers, researchers, industry partners, and community advocates from across the T1D ecosystem.